KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,145 | +30.0% | 2,196 | +5.4% | 0.00% | – |
| Q2 2023 | $29,343 | -31.9% | 2,084 | -47.9% | 0.00% | – |
| Q1 2023 | $43,062 | -98.8% | 4,002 | -98.3% | 0.00% | – |
| Q4 2022 | $3,460,275 | +9.4% | 230,993 | -6.2% | 0.00% | – |
| Q3 2022 | $3,163,000 | +32.6% | 246,364 | +0.0% | 0.00% | – |
| Q2 2022 | $2,386,000 | -2.5% | 246,246 | +0.0% | 0.00% | – |
| Q1 2022 | $2,447,000 | +14.1% | 246,210 | +35.2% | 0.00% | – |
| Q4 2021 | $2,144,000 | -38.4% | 182,140 | -40.4% | 0.00% | – |
| Q3 2021 | $3,480,000 | -18.2% | 305,540 | 0.0% | 0.00% | – |
| Q2 2021 | $4,256,000 | -49.9% | 305,540 | -33.5% | 0.00% | -100.0% |
| Q1 2021 | $8,501,000 | -5.1% | 459,240 | -9.4% | 0.00% | 0.0% |
| Q4 2020 | $8,961,000 | +15.3% | 507,140 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,769,000 | +16.0% | 507,140 | +93.0% | 0.00% | 0.0% |
| Q2 2020 | $6,696,000 | +254.8% | 262,806 | +115.6% | 0.00% | – |
| Q1 2020 | $1,887,000 | -78.0% | 121,900 | -80.8% | 0.00% | -100.0% |
| Q2 2019 | $8,592,000 | -25.6% | 634,539 | -0.7% | 0.00% | 0.0% |
| Q1 2019 | $11,544,000 | -35.7% | 639,230 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $17,956,000 | -5.6% | 639,230 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $19,026,000 | +30.6% | 778,085 | -13.9% | 0.00% | 0.0% |
| Q2 2018 | $14,565,000 | – | 903,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |